Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

StandardStandard

Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis. / Elamanchi, S.R.; Maddison, P.J.; Marcora, S.M. et al.
Yn: Rheumatology, Cyfrol 45, Rhif Supplement 1, 01.04.2006, t. I58-I59.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Elamanchi, SR, Maddison, PJ, Marcora, SM, Lemmey, AB & Casanova, F 2006, 'Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis.', Rheumatology, cyfrol. 45, rhif Supplement 1, tt. I58-I59.

APA

Elamanchi, S. R., Maddison, P. J., Marcora, S. M., Lemmey, A. B., & Casanova, F. (2006). Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis. Rheumatology, 45(Supplement 1), I58-I59.

CBE

Elamanchi SR, Maddison PJ, Marcora SM, Lemmey AB, Casanova F. 2006. Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis. Rheumatology. 45(Supplement 1):I58-I59.

MLA

Elamanchi, S.R. et al. "Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis.". Rheumatology. 2006, 45(Supplement 1). I58-I59.

VancouverVancouver

Elamanchi SR, Maddison PJ, Marcora SM, Lemmey AB, Casanova F. Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis. Rheumatology. 2006 Ebr 1;45(Supplement 1):I58-I59.

Author

Elamanchi, S.R. ; Maddison, P.J. ; Marcora, S.M. et al. / Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis. Yn: Rheumatology. 2006 ; Cyfrol 45, Rhif Supplement 1. tt. I58-I59.

RIS

TY - JOUR

T1 - Nandrolone decaonate as adjunct therapy in male patients with rheumatoid arthritis.

AU - Elamanchi, S.R.

AU - Maddison, P.J.

AU - Marcora, S.M.

AU - Lemmey, A.B.

AU - Casanova, F.

PY - 2006/4/1

Y1 - 2006/4/1

KW - RHEUMATOLOGY

M3 - Article

VL - 45

SP - I58-I59

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - Supplement 1

ER -